Hepatocellular Carcinoma, Radiotherapy, Sorafenib
1 clinical trials · Condition
◉ Watch Hepatocellular Carcinoma, Radiotherapy, Sorafenib
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma (NCT03535259) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2018-05-08 |
Track Hepatocellular Carcinoma, Radiotherapy, Sorafenib automatically
Every clearance here is in the API, with alerts when new ones post.